title: Microbiology. Pyrazinamide--old TB drug finds new target.
authors.affiliation: Global Health Institute, École Polytechnique Fédérale de Lausanne, Station 15, CH-1015 Lausanne, Switzerland. stewart.cole@epfl .ch
authors.forename: Stewart T
authors.initials: ST
authors.lastname: Cole
mesh_terms: D000995:Antitubercular Agents / Q000378:metabolism / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000378:metabolism*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D011355:Prodrugs / Q000378:metabolism / Q000494:pharmacology; D014176:Protein Biosynthesis / Q000187:drug effects*; D011718:Pyrazinamide / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D012329:RNA, Bacterial / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012343:RNA, Transfer / Q000378:metabolism; D012269:Ribosomal Proteins / Q000378:metabolism*
chemical_list: D000995:Antitubercular Agents; D001426:Bacterial Proteins; D011355:Prodrugs; D012329:RNA, Bacterial; D012333:RNA, Messenger; D012269:Ribosomal Proteins; C015494:ribosomal protein S1; C096222:tmRNA; D011718:Pyrazinamide; C005296:pyrazinoic acid; D012343:RNA, Transfer